Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Chiei-Gallo

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Contact Dermatitis|December 14, 2025
Patch Testing Under Biologics: Six Cases From a Tertiary CentreAlessandra Chiei-Gallo, Francesca Barei, Angelo V Marzano, et al.
Clinical Case Reports|October 17, 2022
Successful fractionated undiluted doses of COVID-19 vaccine in five cases of suspected allergic reactions to the first doseFederica Rivolta, Cappelletti Camilla, Andrea Sangalli, et al.
International Journal of Dermatology|July 18, 2024
Tralokinumab-induced psoriasis relapse in a patient with atopic dermatitisAlessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini, et al.
Clinical Case Reports|March 27, 2023
Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritisFederica Rivolta, Andrea Sangalli, Camilla Cappelletti, et al.
International Journal of Dermatology|January 10, 2024
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areataGianluca Tavoletti, Alessandra Chiei-Gallo, Francesca Barei, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 23, 2026
<i>Letter:</i> Characterizing Atopic Dermatitis Flares During Tralokinumab Therapy: A Real-World ExperienceFrancesca Barei, Alessandra Chiei Gallo, Martina Zussino, et al.
Clinical and Experimental Dermatology|October 10, 2024
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitisAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
International Journal of Dermatology|July 28, 2025
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular EczemaFrancesca Barei, Alessandra Chiei Gallo, Roberto Pinto, et al.
International Journal of Dermatology|October 13, 2024
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life studyAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
Italian Journal of Dermatology and Venereology|November 4, 2024
The potential of upadacitinib in treating co-occurring atopic dermatitis and ulcerative colitisGiovanni Lasagni, Gianluca Tavoletti, Carlo A Maronese, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Contact Dermatitis|December 14, 2025
Patch Testing Under Biologics: Six Cases From a Tertiary CentreAlessandra Chiei-Gallo, Francesca Barei, Angelo V Marzano, et al.
Clinical Case Reports|October 17, 2022
Successful fractionated undiluted doses of COVID-19 vaccine in five cases of suspected allergic reactions to the first doseFederica Rivolta, Cappelletti Camilla, Andrea Sangalli, et al.
International Journal of Dermatology|July 18, 2024
Tralokinumab-induced psoriasis relapse in a patient with atopic dermatitisAlessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini, et al.
Clinical Case Reports|March 27, 2023
Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritisFederica Rivolta, Andrea Sangalli, Camilla Cappelletti, et al.
International Journal of Dermatology|January 10, 2024
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areataGianluca Tavoletti, Alessandra Chiei-Gallo, Francesca Barei, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 23, 2026
<i>Letter:</i> Characterizing Atopic Dermatitis Flares During Tralokinumab Therapy: A Real-World ExperienceFrancesca Barei, Alessandra Chiei Gallo, Martina Zussino, et al.
Clinical and Experimental Dermatology|October 10, 2024
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitisAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
International Journal of Dermatology|July 28, 2025
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular EczemaFrancesca Barei, Alessandra Chiei Gallo, Roberto Pinto, et al.
International Journal of Dermatology|October 13, 2024
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life studyAlessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, et al.
Italian Journal of Dermatology and Venereology|November 4, 2024
The potential of upadacitinib in treating co-occurring atopic dermatitis and ulcerative colitisGiovanni Lasagni, Gianluca Tavoletti, Carlo A Maronese, et al.
Pageof 3